Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

NCT00927186 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Post-menopausal

Interventions

DRUG: Teriparatide
DRUG: Zoledronic Acid

Sponsor

Eli Lilly and Company